{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:06:01Z","timestamp":1790193961350,"version":"4.1.0"},"reference-count":40,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Insulinoma-associated protein-1 (INSM1) is a recently developed immunohistochemical marker claimed to be highly specific and sensitive for the diagnosis of neuroendocrine malignancies. Recent studies, however, have demonstrated that this marker can also be expressed in non-neuroendocrine neoplasms including squamous cell carcinoma of the thymus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To examine INSM1 expression in lymphoepithelial thymic carcinomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Thirty-four cases of lymphoepithelial carcinoma of the thymus were examined by immunohistochemistry or in situ hybridization for INSM1, synaptophysin, chromogranin, CD5, CD117, Epstein-Barr virus\u2013encoded small ribonucleic acid (EBER), and Ki-67. Basic clinical information was abstracted from the medical record.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The patients were 14 women and 20 men, aged 20 to 85 years. The tumors arose in the anterior mediastinum without any previous history or evidence of malignancy at other sites. Immunohistochemical staining showed moderate to strong positivity of the tumor cells for INSM1 in 65% of cases (22 of 34), focal weak positivity in 20% (7 of 34), and negative staining in 5 cases. Chromogranin staining was focally and weakly positive in 1 case, and synaptophysin showed only focal weak positivity in scattered tumor cells in 12 cases. No significant correlation could be identified between the pattern and intensity of staining for INSM1 and staining for CD5, CD117, and Ki-67.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>INSM1 positivity in lymphoepithelial carcinoma of the thymus may represent a pitfall for diagnosis, particularly in small biopsy samples. Awareness of this finding may be of importance to avoid misdiagnosis of neuroendocrine malignancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0045-oa","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:25:51Z","timestamp":1718616351000},"page":"e31-e35","source":"Crossref","is-referenced-by-count":4,"title":["Insulinoma-Associated Protein-1 Expression in Lymphoepithelial Carcinoma of the Thymus: A Potential Pitfall for Diagnosis With Neuroendocrine Carcinomas of the Thymus"],"prefix":"10.5858","volume":"149","author":[{"given":"David I.","family":"Suster","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Rutgers University, New Jersey Medical School, Newark (D Suster, S Suster)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Craig","family":"Mackinnon","sequence":"additional","affiliation":[{"name":"the Department of Pathology, University of Alabama at Birmingham, Birmingham (Mackinnon)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Suster","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Rutgers University, New Jersey Medical School, Newark (D Suster, S Suster)"},{"name":"the Department of Pathology, Medical College of Wisconsin, Milwaukee (S Suster)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b01","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.emboj.7601011","article-title":"IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas","volume":"25","author":"Mellitzer","year":"2006","journal-title":"EMBO J"},{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b02","article-title":"INSM1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing, and neurogenic","volume":"6","author":"Rosenbaum","year":"2011","journal-title":"Neural Dev"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b03","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2023.05.001","article-title":"Expression of neuroendocrine markers in meningeal and extrameningeal solitary fibrous tumors: a potential diagnostic pitfall","volume":"137","author":"Gerykova","year":"2023","journal-title":"Hum Pathol"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b04","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.humpath.2022.12.005","article-title":"Extraskeletal myxoid chondrosarcoma: a study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphologic variants associated with non-EWSR1::NR4A fusions","volume":"134","author":"Lenz","year":"2023","journal-title":"Hum Pathol"},{"issue":"3","key":"2025012723504035900_i1543-2165-149-2-e31-b05","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ajcp\/aqaa250","article-title":"INSM1 expression in chordomas","volume":"156","author":"Dridi","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2025012723504035900_i1543-2165-149-2-e31-b06","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ajcp\/aqaa168","article-title":"INSM1 expression in angiosarcoma","volume":"155","author":"Warmke","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2025012723504035900_i1543-2165-149-2-e31-b07","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41379-020-0517-0","article-title":"INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma","volume":"33","author":"Tsai","year":"2020","journal-title":"Mod Pathol"},{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b08","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00428-022-03437-x","article-title":"Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma","volume":"481","author":"Kashima","year":"2022","journal-title":"Virchows Arch"},{"issue":"9","key":"2025012723504035900_i1543-2165-149-2-e31-b09","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/PAS.0000000000001101","article-title":"Poorly-differentiated non-keratinizing squamous cell carcinoma of the thymus: clinicopathologic and molecular genetic study of 25 cases","volume":"42","author":"Suster","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2025012723504035900_i1543-2165-149-2-e31-b10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma: a clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00313029800169056","article-title":"Thymic carcinoma: spectrum of differentiation and histologic types","volume":"30","author":"Suster","year":"1998","journal-title":"Pathology"},{"issue":"3","key":"2025012723504035900_i1543-2165-149-2-e31-b12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semdp.2006.02.006","article-title":"Thymic carcinoma: update of current diagnostic criteria and histologic types","volume":"22","author":"Suster","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b13","volume-title":"WHO Classification of Tumors: Thoracic Tumors","author":"WHO Classification of Tumors Editorial Board.","year":"2021","edition":"5th ed"},{"issue":"9","key":"2025012723504035900_i1543-2165-149-2-e31-b14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00000478-199809000-00003","article-title":"Neuroendocrine differentiation is a common feature of thymic carcinoma","volume":"22","author":"Lauriola","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2025012723504035900_i1543-2165-149-2-e31-b15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0046-8177(98)90112-5","article-title":"Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma","volume":"29","author":"Hishima","year":"1998","journal-title":"Hum Pathol"},{"issue":"21","key":"2025012723504035900_i1543-2165-149-2-e31-b16","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1016\/S0021-9258(18)42173-4","article-title":"A novel human insulinoma-associated cDNA, IA-1, encodes a protein with \u201czinc-finger\u201d DNA binding motifs","volume":"267","author":"Goto","year":"1992","journal-title":"J Biol Chem"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2002.6800","article-title":"The zinc-finger transcription factor INSM-1 is express during embryo development and interacts with the Cbl-associated protein","volume":"80","author":"Xie","year":"2002","journal-title":"Genomics"},{"issue":"4","key":"2025012723504035900_i1543-2165-149-2-e31-b18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cne.21629","article-title":"Transient expression of the conserved zinc finger gene INSM-1 in progenitor and nascent neurons throughout embryonic and adult neurogenesis","volume":"504","author":"Duggan","year":"2008","journal-title":"J Comp Neurol"},{"issue":"4","key":"2025012723504035900_i1543-2165-149-2-e31-b19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41379-018-0122-7","article-title":"Insulinoma-associated protein-1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections","volume":"32","author":"Mukhopadhayay","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jasc.2019.06.002","article-title":"Insulinoma-associated protein-1 is a sensitive and specific marker for lung neuroendocrine tumors in cytological and surgical specimens","volume":"8","author":"Viswanathan","year":"2019","journal-title":"J Am Soc Cytopathol"},{"issue":"9","key":"2025012723504035900_i1543-2165-149-2-e31-b22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.5858\/arpa.2019-0250-OA","article-title":"Diagnostic value of Insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers","volume":"144","author":"Staaf","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"2025012723504035900_i1543-2165-149-2-e31-b23","doi-asserted-by":"crossref","first-page":"E2662","DOI":"10.1002\/lary.29554","article-title":"Application of INSM1 in diagnosis and grading of laryngeal neuroendocrine carcinoma","volume":"131","author":"Yuan","year":"2021","journal-title":"Laryngoscope"},{"issue":"2","key":"2025012723504035900_i1543-2165-149-2-e31-b24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12105-021-01367-9","article-title":"Neuroendocrine neoplasms of the larynx: a clinicopathologic analysis of 27 neuroendocrine tumors and neuroendocrine carcinomas","volume":"16","author":"Bal","year":"2020","journal-title":"Head Neck Pathol"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-022-01346-5","article-title":"Optimal combination of neuroendocrine markers for the detection of high-grade neuroendocrine tumors of the sinonasal tract and lung","volume":"25","author":"Weissferdt","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12022-021-09682-1","article-title":"INSM1 expression in breast neoplasms with neuroendocrine features","volume":"32","author":"Metovic","year":"2021","journal-title":"Endocr Pathol"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2022.06.003","article-title":"Expression of novel neuroendocrine markers in breast carcinomas: a study of ISNM1, ASCL1, and POU2F3","volume":"127","author":"Zhong","year":"2022","journal-title":"Hum Pathol"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00795-017-0167-6","article-title":"Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor","volume":"51","author":"Tanigawa","year":"2018","journal-title":"Med Mol Morphol"},{"issue":"2","key":"2025012723504035900_i1543-2165-149-2-e31-b29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00428-021-03211-5","article-title":"Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls","volume":"480","author":"Konukiewitz","year":"2022","journal-title":"Virchows Arch"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anndiagpath.2019.04.002","article-title":"A new immunohistochemical marker, insulinoma-associated protein-1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases","volume":"40","author":"Leblebici","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41379-021-00921-8","article-title":"Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis","volume":"35","author":"Goto","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"2025012723504035900_i1543-2165-149-2-e31-b32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5114\/pjp.2021.106440","article-title":"The diagnostic utility of INSM1 and GATA3 in discriminating problematic medullary thyroid carcinoma, thyroid, and parathyroid lesions","volume":"72","author":"Hakim","year":"2021","journal-title":"Pol J Pathol"},{"issue":"5","key":"2025012723504035900_i1543-2165-149-2-e31-b33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PGP.0000000000000722","article-title":"Insulinoma-associated protein 1 expression and its diagnostic significance in female genital tract neuroendocrine carcinomas","volume":"40","author":"Ting","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ajcp\/aqaa014","article-title":"INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas","volume":"153","author":"McHugh","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2025012723504035900_i1543-2165-149-2-e31-b35","doi-asserted-by":"crossref","first-page":"152993","DOI":"10.1016\/j.prp.2020.152993","article-title":"Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: an immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56","volume":"216","author":"Chen","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"11","key":"2025012723504035900_i1543-2165-149-2-e31-b36","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000000916","article-title":"INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity","volume":"41","author":"Rooper","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2025012723504035900_i1543-2165-149-2-e31-b37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you","volume":"96","author":"Bellizi","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"2025012723504035900_i1543-2165-149-2-e31-b38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lungcan.2012.12.001","article-title":"Treatment, prognostic markers and survival in thymic neuroendocrine tumors: a study from a single tertiary referral center","volume":"79","author":"Crona","year":"2013","journal-title":"Lung Cancer"},{"issue":"43","key":"2025012723504035900_i1543-2165-149-2-e31-b39","doi-asserted-by":"crossref","first-page":"e7842","DOI":"10.1097\/MD.0000000000007842","article-title":"Treatment, prognostic markers and survival in thymic neuroendocrine tumors","volume":"96","author":"Ma","year":"2017","journal-title":"Medicine (Baltimore"},{"issue":"12","key":"2025012723504035900_i1543-2165-149-2-e31-b40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41379-018-0097-4","article-title":"Expression of PD-L1\/PD-1 in lymphoepithelioma-like carcinoma of the thymus","volume":"31","author":"Suster","year":"2018","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/2\/e31\/3480231\/i1543-2165-149-2-e31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/2\/e31\/3480231\/i1543-2165-149-2-e31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:43Z","timestamp":1764790903000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/2\/article-pe31.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,17]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0045-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}